173 related articles for article (PubMed ID: 35864518)
21. English Bulldogs in the UK: a VetCompass study of their disorder predispositions and protections.
O'Neill DG; Skipper A; Packer RMA; Lacey C; Brodbelt DC; Church DB; Pegram C
Canine Med Genet; 2022 Jun; 9(1):5. PubMed ID: 35701824
[TBL] [Abstract][Full Text] [Related]
22. Mortality related to general anaesthesia and sedation in dogs under UK primary veterinary care.
Shoop-Worrall SJ; O'Neill DG; Viscasillas J; Brodbelt DC
Vet Anaesth Analg; 2022 Sep; 49(5):433-442. PubMed ID: 35985925
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of hyperadrenocorticism among 210,824 dogs attending primary-care veterinary practices in the UK from 2009 to 2014.
O'Neill DG; Scudder C; Faire JM; Church DB; McGreevy PD; Thomson PC; Brodbelt DC
J Small Anim Pract; 2016 Jul; 57(7):365-73. PubMed ID: 27279104
[TBL] [Abstract][Full Text] [Related]
24. Non-neoplastic anal sac disorders in UK dogs: Epidemiology and management aspects of a research-neglected syndrome.
O'Neill DG; Hendricks A; Phillips JA; Brodbelt DC; Church DB; Loeffler A
Vet Rec; 2021 Jul; 189(2):e203. PubMed ID: 33645764
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of environmental risk factors for leptospirosis in dogs: 36 cases (1997-2002).
Ward MP; Guptill LF; Wu CC
J Am Vet Med Assoc; 2004 Jul; 225(1):72-7. PubMed ID: 15239476
[TBL] [Abstract][Full Text] [Related]
26. Breed distribution of spontaneous chronic corneal epithelial defects in UK dogs.
Bradley C; Sansom PG; Carter WJ
Vet Rec; 2023 Mar; 192(5):e2031. PubMed ID: 36030371
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of commercially available vaccines against canine leptospirosis: A systematic review and meta-analysis.
Bergmann Esteves S; Moreira Santos C; Ferreira Salgado F; Paldês Gonçales A; Gil Alves Guilloux A; Marinelli Martins C; Kuribaiashi Hagiwara M; Alonso Miotto B
Vaccine; 2022 Mar; 40(12):1722-1740. PubMed ID: 35153090
[TBL] [Abstract][Full Text] [Related]
28. Distribution of Leptospira serogroups in dogs from Berlin, Germany.
Mayer-Scholl A; Luge E; Draeger A; Nöckler K; Kohn B
Vector Borne Zoonotic Dis; 2013 Mar; 13(3):200-2. PubMed ID: 23428087
[TBL] [Abstract][Full Text] [Related]
29. French Bulldogs differ to other dogs in the UK in propensity for many common disorders: a VetCompass study.
O'Neill DG; Packer RMA; Francis P; Church DB; Brodbelt DC; Pegram C
Canine Med Genet; 2021 Dec; 8(1):13. PubMed ID: 34911586
[TBL] [Abstract][Full Text] [Related]
30. Signalment changes in canine leptospirosis between 1970 and 2009.
Lee HS; Guptill L; Johnson AJ; Moore GE
J Vet Intern Med; 2014; 28(2):294-9. PubMed ID: 24372922
[TBL] [Abstract][Full Text] [Related]
31. Vestibular disease in dogs under UK primary veterinary care: Epidemiology and clinical management.
Radulescu SM; Humm K; Eramanis LM; Volk HA; Church DB; Brodbelt D; O'Neill DG
J Vet Intern Med; 2020 Sep; 34(5):1993-2004. PubMed ID: 32776616
[TBL] [Abstract][Full Text] [Related]
32. Canine leptospirosis--do we have a problem?
André-Fontaine G
Vet Microbiol; 2006 Oct; 117(1):19-24. PubMed ID: 16684591
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970-1998).
Ward MP; Glickman LT; Guptill LE
J Am Vet Med Assoc; 2002 Jan; 220(1):53-8. PubMed ID: 12680448
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care.
Anderson KL; O'Neill DG; Brodbelt DC; Church DB; Meeson RL; Sargan D; Summers JF; Zulch H; Collins LM
Sci Rep; 2018 Apr; 8(1):5641. PubMed ID: 29618832
[TBL] [Abstract][Full Text] [Related]
35. Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bi-valent inactivated leptospirosis vaccine.
Minke JM; Bey R; Tronel JP; Latour S; Colombet G; Yvorel J; Cariou C; Guiot AL; Cozette V; Guigal PM
Vet Microbiol; 2009 May; 137(1-2):137-45. PubMed ID: 19179023
[TBL] [Abstract][Full Text] [Related]
36. Canine leptospirosis in Canada, test-positive proportion and risk factors (2009 to 2018): A cross-sectional study.
Stull JW; Evason M; Weese JS; Yu J; Szlosek D; Smith AM
PLoS One; 2022; 17(6):e0270313. PubMed ID: 35749480
[TBL] [Abstract][Full Text] [Related]
37. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine.
Klaasen HL; Molkenboer MJ; Vrijenhoek MP; Kaashoek MJ
Vet Microbiol; 2003 Aug; 95(1-2):121-32. PubMed ID: 12860082
[TBL] [Abstract][Full Text] [Related]
38. Canine vaccination in Germany: A survey of owner attitudes and compliance.
Eschle S; Hartmann K; Rieger A; Fischer S; Klima A; Bergmann M
PLoS One; 2020; 15(8):e0238371. PubMed ID: 32853287
[TBL] [Abstract][Full Text] [Related]
39. Leptospirosis in dogs.
Prescott JF; Key D; Osuch M
Can Vet J; 1999 Jun; 40(6):430-1. PubMed ID: 10367164
[No Abstract] [Full Text] [Related]
40. Experiements with an inactivated hepatitis leptospirosis vaccine in vaccination programmes for dogs.
Wilson JH; Hermann-Dekkers WM; Leemans-Dessy S; Meijer JW
Vet Rec; 1977 Jun; 100(26):552-4. PubMed ID: 196386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
